98%
921
2 minutes
20
Dried blood spot (DBS) sampling by finger-pricking has recently gained a lot of interest as an alternative sample collection method. The reduced invasiveness, requirement of lower sample volumes and suitability for long-term storage at room temperature make DBS ideal for use in home settings or low-resource environments. However, traditional protocols often suffer from biased analysis data due to variable and not exactly known blood volumes present in the samples. In this work, a novel device has been developed to split-off precisely metered volumes from a blood drop and load them on pre-cut filter paper. Hereto, hydrophobic burst valves (HBV) were developed to temporarily retain a fluid flow, configurable to burst at pressures within a range of 175-600 Pa. By combining HBVs with different burst pressures, a volume metering system was developed to allow parallel metering of multiple pre-defined sample volumes. The system was shown to be accurate and consistent for blood volumes between 5-15 μL and for hematocrit levels spanning the range of 25-70%. Finally, a point-of-care DBS sampling device was developed combining the self-powered microfluidic SIMPLE technology. To evaluate the system's practical applicability, a validation study in the context of therapeutic drug monitoring of biologicals was performed using adalimumab-spiked blood samples. Microfluidic DBS samples showed good performance compared to the traditional DBS method with improved recovery rates (86% over 62%). This innovative metering system, allowing for parallelization and integration with complex liquid manipulations, will greatly impact the field of robust sampling, sample preparation, storage and analysis at the point-of-care.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d1lc00422k | DOI Listing |
J Control Release
September 2025
LEO Foundation Center for Cutaneous Drug Delivery, Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark. Electronic address:
In situ forming implants (ISFIs) present a promising approach for sustained parenteral drug delivery, offering reduced first pass metabolism, fewer systemic side effects, and improved patient compliance. This study investigates defocused spatially-offset Raman spectroscopy (SORS) as a real-time, non-invasive, and label-free method for monitoring implant formation and drug release from ISFIs loaded with the model drugs 4-cyanophenol (4-CP) or all-trans retinoic acid (RA). A custom-designed flow-through diffusion cell, incorporating full-thickness porcine skin, was developed to enable ex vivo release studies, allowing simultaneous defocused SORS measurements of subcutaneously-implanted formulations and HPLC quantification of drug released into the receptor medium.
View Article and Find Full Text PDFPharmaceutics
August 2025
Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Controlled release systems, such as polymeric microparticles (MPs), have emerged as a promising solution to extend the bioavailability and reduce dosing frequency for biologic drugs; however, the formulation of these systems to encapsulate highly sensitive, hydrophilic biologic drugs within hydrophobic polymers remains a nontrivial task. Although scalable manufacturing and FDA approval of single emulsion processes encapsulating small molecules has been achieved, scaling more complex double emulsion processes to encapsulate hydrophilic biologics remains more challenging. : Here, we demonstrate that two hydrophilic, low-molecular-weight, recombinant chemokines, CCL22 and CCL2, can be encapsulated in poly(lactic-co-glycolic acid) (PLGA) MPs using a single emulsion method where the proteins are dissolved in an organic solvent during formulation.
View Article and Find Full Text PDFBiomolecules
August 2025
Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-220, Brazil.
Antimicrobial peptides (AMPs) are a primary defense against pathogens. Here, we examined the interaction of two BP100 analogs, RR-BP100 (where Arg substitutes Lys 2 and 5) and RR-BP100-A-NH-C (where an Ala and a C hydrocarbon chain are added to the RR-BP100 C-terminus), with membrane models. Large unilamellar vesicles (LUVs) and giant unilamellar vesicles (GUVs) were prepared with the major lipids in Gram-positive (GP) and Gram-negative (GN) bacteria, as well as red blood cells (RBCs).
View Article and Find Full Text PDFACS Omega
August 2025
Department of Chemistry, Bioscience, and Environmental Engineering, University of Stavanger, Stavanger 4036, Norway.
Pluronic F127 is widely used for hydrogel preparation, but its low gelation temperature (21 °C at a concentration of 25 wt %) and limited ability to deliver hydrophobic drugs hinder medical applications. A standard approach to address these limitations involves combining Pluronic F127 with other polydisperse polymers, further increasing the system complexity. This study demonstrates the use of monodisperse and high-purity poly-(propylene glycol)-8 (PPG-8), obtained via cost-effective chromatographic purification, as a polymeric modifier.
View Article and Find Full Text PDFLab Chip
August 2025
Department of Biomedical Sciences and Engineering, Koç University, Sariyer, Istanbul, Turkey 34450.
Point-of-care (PoC) devices have revolutionized healthcare by enabling remote diagnostics and therapeutics, with microfluidic systems playing a pivotal role in their advancement. This study focuses on the detailed engineering and characterization of three-dimensional hydrophobic valves to form novel programmable bio-reaction reservoirs. Using 3D-printed soft lithography, we meticulously investigated the effects of channel dimensions and surface properties on the burst pressures of these reservoirs, which ranged from 6.
View Article and Find Full Text PDF